Shortened postpartum magnesium sulfate treatment vs traditional 24h for severe preeclampsia: a systematic review and meta-analysis of randomized trials

References

• Villar J, Abalos E, Nardin JM, et al. Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol. 2004;24(6):607–615.
   PubMed Web of Science ®Google Scholar
• Duley L, Gu Lmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010, 10;(11);CD000025.
   PubMed Web of Science ®Google Scholar
• Vigil-De Gracia P, Rojas-Suarez J, Ramos E, et al. Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America. Int J Gynaecol Obstet. 2015;129(3):219–222.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol. 2004;190(6):1520–1526.
   PubMed Web of Science ®Google Scholar
• Vigil-De Gracia P, Ludmir J. The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period. J Matern Fetal Neonatal Med. 2015;28(18):2207–2209.
   PubMed Web of Science ®Google Scholar
• Kumpalum J, Jirasettasiri P. Shortened postpartum magnesium sulfate treatment for severe preeclampsia. Thai J Obst Gynaecol. 2010;18(2):63–69.
   Google Scholar
• Maia Sabina B, Leila K, Noronha NC, et al. Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium sulfate therapy in severe preeclampsia. Int J Gynaecol Obstet. 2014;126(3):260–264.
   PubMed Web of Science ®Google Scholar
• Leal NV, Amorim MM, Franca-Neto AH, et al. 12-hour compared with 24-hour postpartum magnesium sulfate therapy in preeclampsia: a randomized clinical trial. Obstet Gynecol. 2014;123:64S.
   Web of Science ®Google Scholar
• El-Khayat W, Atef A, Abdelatty S, et al. A novel protocol for postpartum magnesium sulphate in severe pre-eclampsia: a randomized controlled pilot trial. J Matern Fetal Neonatal Med. 2016;29:154–158.
   PubMed Web of Science ®Google Scholar
• Kashanian M, Koohpayehzadeh J, Sheikhansari N, et al. A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia. J Matern Fetal Neonatal Med. 2016;29:2282–2287.
   PubMed Web of Science ®Google Scholar
• Shaheen A, Pramod RG, Imam B, et al. Short-course postpartum (6-h) magnesium sulfate therapy in severe preeclampsia. Arch Gynecol Obstet. 2016;293:983–986.
   PubMed Web of Science ®Google Scholar
• Vigil-De Gracia P, Ramirez R, Duran Y, et al. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial. BMC Pregnancy Childbirth. 2017;17. DOI:10.1186/s12884-017-1424-3.
   PubMed Web of Science ®Google Scholar
• Gordon R, Magee LA, Payne B, et al. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens. J Obstet Gynaecol Can. 2014;36:154–163.
   PubMedGoogle Scholar
• Isler CM, Barrilleaux PS, Rinehart BK, et al. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. Obstet Gynecol. 2003;101:66–69.
   PubMed Web of Science ®Google Scholar
• Ascarelli MH, Johnson V, May WL, et al. Individually determined postpartum magnesium sulphate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia. Am J Obstet Gynecol. 1998;179:952–956.
   PubMed Web of Science ®Google Scholar
• Fontenot MT, Lewis DF, Frederick JB, et al. A prospective randomized trial of magnesium sulphate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy. Am J Obstet Gynecol. 2005;192:1788–1794.
   PubMed Web of Science ®Google Scholar
• Darngawn L, Jose R, Regi A, et al. A shortened postpartum magnesium sulfate prophylaxis regime in pre-eclamptic women at low risk of eclampsia. Int J Gynecol Obstet. 2012;116(3):237–239.
   PubMed Web of Science ®Google Scholar
• Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol. 2006;108(4):833–838.
   PubMed Web of Science ®Google Scholar
• Regmi MC, Aggrawal A, Pradhan T, et al. Loading dose versus standard regimen of magnesium sulphate in eclampsia–a randomized trial. Nepal Med Coll J. 2010;12:244–247.
   Google Scholar
• Begum MR, Begum A, Quadir E, et al. Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial. J Obstet Gynaecol Res. 2002;28:154–159.
   PubMed Web of Science ®Google Scholar
• Shoaib T, Khan S, Javed I, et al. Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia. J Coll Physicians Surg Pak. 2009;19:30–33.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee N, Saha SP, Ganguly RP, et al. A randomised comparative study between low-dose intravenous magnesium sulphate and standard intramuscular regimen for treatment of eclampsia. J Obstet Gynaecol. 2011;31:298–303.
   PubMedGoogle Scholar
• Chissell S, Botha JH, Moodley J, et al. Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia. S Afr Med J. 1994;84:607–610.
   PubMed Web of Science ®Google Scholar
• Ludmir J, Vigil-De GP. Is magnesium sulfate use of benefit post partum? A randomized controlled trial. Am J Obstet Gynecol. 2017;216:S3–S4.
   Google Scholar
• McDonald SD, Lutsiv O, Dzaja N, et al. A systematic review of maternal and infant outcomes following magnesium sulfate for preeclampsia/eclampsia in real-world use. Int J Gynaecol Obstet. 2012;118:90–96.
   PubMed Web of Science ®Google Scholar
• Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy Childbirth. 2013;13:195.
   PubMed Web of Science ®Google Scholar